share_log

Maxim Group Cuts VerifyMe (NASDAQ:VRME) Price Target to $7.00

kopsource ·  Aug 20, 2022 02:31

VerifyMe (NASDAQ:VRME – Get Rating) had its target price reduced by Maxim Group from $10.00 to $7.00 in a research note issued to investors on Wednesday morning, The Fly reports. They currently have a buy rating on the stock.

A number of other equities analysts have also commented on the stock. TheStreet lowered shares of VerifyMe from a c- rating to a d+ rating in a research report on Tuesday, June 21st. Barrington Research started coverage on shares of VerifyMe in a research report on Thursday, July 14th. They issued an outperform rating and a $8.00 price target on the stock.

Get VerifyMe alerts:

VerifyMe Trading Down 9.5 %

NASDAQ:VRME opened at $1.34 on Wednesday. VerifyMe has a 12 month low of $1.32 and a 12 month high of $4.28. The firm has a market cap of $11.35 million, a price-to-earnings ratio of -1.49 and a beta of 1.02. The company has a quick ratio of 14.74, a current ratio of 2.51 and a debt-to-equity ratio of 0.11. The company's 50 day moving average is $1.89 and its 200-day moving average is $2.61.

About VerifyMe

(Get Rating)

VerifyMe, Inc, a technology solutions provider, provides products to connect brands with consumers in the United States. The company offers VerifyMe Engage services that provides the ability for the brand owner to gather business intelligence and engage with the consumer using authentication test as the initial contact with the consumer.

Read More

  • Get a free copy of the StockNews.com research report on VerifyMe (VRME)
  • 2 EV Suppliers Powering To Gains After Raising Views
  • Applied Materials Results Show A Slowing Semiconductor Market
  • MarketBeat: Week in Review 8/15 – 8/19
  • Near-Term Headwinds Present An Opportunity In Ross Stores
  • Apple's Stock Could Be On The Verge Of Another 30% Rally

Receive News & Ratings for VerifyMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VerifyMe and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment